Position in AMGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,271,442,965
-$175,795,173 QoQ
Shares Held
6,272,625
-9.8% QoQ
Ownership
1.16%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#12
of 3,131 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital Research Global Investors holds $40,525,577,269 across 9 Drug Manufacturers - General names. AMGN ranks #4 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
20,873,140 | $25,035,872,397 | |
| 2 | ABBV |
AbbVie Inc.
|
30,101,551 | $7,574,754,293 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
19,393,296 | $2,450,149,016 | |
| 4 | AMGN |
Amgen Inc
This page
|
6,272,625 | $2,271,442,965 | |
| 5 | JNJ |
Johnson & Johnson
|
8,164,545 | $2,073,549,493 | |
| 6 | AZN |
Astrazeneca PLC
|
4,197,587 | $795,946,446 | |
| 7 | MRK |
Merck & Co., Inc.
|
1,925,013 | $247,364,170 | |
| 8 | SNY |
Sanofi
|
1,677,399 | $71,557,841 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,271,442,965 | 6,272,625 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $2,447,238,138 | 6,955,345 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,521,387,613 | 4,648,155 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $1,335,170,038 | 4,731,290 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,286,783,679 | 4,608,659 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,407,729,328 | 4,518,470 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,274,553,578 | 4,890,092 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,305,081,317 | 4,050,406 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,251,194,151 | 4,004,462 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,612,311,336 | 5,670,763 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,931,649,621 | 6,706,651 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $2,282,634,850 | 8,493,209 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,124,684,997 | 9,569,791 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,859,445,350 | 11,828,109 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,130,029,271 | 11,917,565 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,841,226,731 | 12,605,265 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,429,395,248 | 14,095,336 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $4,457,117,662 | 18,431,551 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $4,984,864,112 | 22,157,906 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $5,682,897,089 | 26,724,181 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $7,144,462,893 | 29,310,617 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $8,115,824,908 | 32,618,564 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $7,302,794,223 | 31,762,327 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $8,514,617,464 | 33,501,013 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $7,868,684,429 | 33,361,674 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $6,712,521,060 | 33,110,645 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||